Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -2,758 More Arrow -1,966 Less Arrow -2,028
EBITDA -2,788 More Arrow -1,934 Less Arrow -1,987
Total assets 6,618 Less Arrow 4,943 More Arrow 6,344
Current assets 6,017 Less Arrow 4,652 More Arrow 6,099
Current liabilities 873 Less Arrow 412 Less Arrow 357
Equity capital 5,745 Less Arrow 4,531 More Arrow 5,987
- share capital 65 Less Arrow 59 More Arrow 63
Employees (average) 7 More Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 86.8% More Arrow 91.7% More Arrow 94.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -41.7% More Arrow -39.8% More Arrow -32.0%
Current ratio 689.2% More Arrow 1129.1% More Arrow 1708.4%
Return on equity (ROE) -48.0% More Arrow -43.4% More Arrow -33.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -2 More Arrow 2 Equal arrow 2
Chg. No. of employees % -22% More Arrow 29% More Arrow 40%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.